Northern Trust
BIOA

Northern Trust’s BioAge Labs BIOA Stock Holding History

Northern Trust’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.92M Buy
224,129
+56,677
+34% +$1.09M ﹤0.01% 2593
2025
Q4 		$2.22M Sell
167,452
-19,116
-10% -$169K ﹤0.01% 2936
2025
Q3 		$1.1M Buy
186,568
+33,559
+22% +$157K ﹤0.01% 3362
2025
Q2 		$632K Buy
153,009
+63,441
+71% +$256K ﹤0.01% 3579
2025
Q1 		$337K Buy
89,568
+2,325
+3% +$10.8K ﹤0.01% 3744
2024
Q4 		$505K Buy
+87,243
New +$1.5M ﹤0.01% 3652

Other funds holding BIOA

ACM
AH Capital Management Menlo Park, California $1.29B AUM 26.81% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Northern Trust's BIOA Position: Q1 2026 in Review

Northern Trust increased its BioAge Labs (BIOA) stake by 34% in Q1 2026, buying an estimated $1.09M and bringing the position to 224,129 shares worth $3.92M. The position accounts for ﹤0.01% of the portfolio, ranked #2593.

Northern Trust first reported a position in BIOA in Q4 2024 and has held it in 6 quarters since. 144 funds tracked by Wall St. Rank hold BIOA as of Q1 2026.

  • Northern Trust held 224,129 shares of BioAge Labs worth $3.92M as of Q1 2026.
  • Northern Trust bought 56,677 BioAge Labs shares in Q1 2026, an estimated $1.09M.
  • BioAge Labs made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #2593 holding.
  • Northern Trust first reported a position in BioAge Labs in Q4 2024 and has held it in 6 quarters since.
  • 144 funds tracked by Wall St. Rank held BioAge Labs as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.